Skip Navigation
Skip to contents

JPMPH : Journal of Preventive Medicine and Public Health

OPEN ACCESS
SEARCH
Search

Author index

Page Path
HOME > Browse Articles > Author index
Search
Viroj Wiwanitkit 2 Articles
Social and Policy Determinants of COVID-19
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
J Prev Med Public Health. 2022;55(3):307-307.   Published online May 31, 2022
DOI: https://doi.org/10.3961/jpmph.22.170
  • 2,143 View
  • 92 Download
PDF
Summary
Letter to the Editor: Coronavirus Disease 2019 (COVID-19), Infectivity, and the Incubation Period
Beuy Joob, Viroj Wiwanitkit
J Prev Med Public Health. 2020;53(2):70-70.   Published online March 31, 2020
DOI: https://doi.org/10.3961/jpmph.20.065
  • 7,006 View
  • 357 Download
  • 159 Crossref
PDF
Summary

Citations

Citations to this article as recorded by  
  • Acute interstitial nephritis following COVID-19 vaccination
    Amnuay Kleebayoon, Viroj Wiwanitkit
    Nefrología.2024; 44(2): 312.     CrossRef
  • Correspondence on ‘COVID-19 vaccine triggered autoimmune hepatitis: case report’ by Mathewet al
    Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
    European Journal of Hospital Pharmacy.2024; 31(1): 82.1.     CrossRef
  • Blepharoplasty and COVID-19 Vaccination
    Amnuay Kleebayoon, Viroj Wiwanitkit
    Aesthetic Plastic Surgery.2024; 48(1): 55.     CrossRef
  • In Reference to Otolaryngologic Side Effects After COVID‐19 Vaccination
    Amnuay Kleebayoon, Viroj Wiwanitkit
    The Laryngoscope.2024;[Epub]     CrossRef
  • Using Immunoglobulin G Spike Antibodies as a Surrogate Marker for SARS-CoV-2 Infection: Additional Considerations
    Hinpetch Daungsupawong, Viroj Wiwanitkit
    Kidney Medicine.2024; 6(1): 100780.     CrossRef
  • Comment on “SARS-CoV-2 vaccine safety and COVID-19 risk perception in hematopoietic stem cell transplant recipients”
    Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
    Supportive Care in Cancer.2024;[Epub]     CrossRef
  • Evaluation of T and B cell immunophenotyping and antibody response to Covid-19 vaccine: Comment
    Amnuay Kleebayoon, Viroj Wiwanitkit
    Indian Journal of Medical Microbiology.2024; 48: 100463.     CrossRef
  • Re: ‘Effectiveness of a fourth SARS‐CoV‐2 vaccine dose in previously infected individuals’
    Hinpetch Daungsupawong, Viroj Wiwanitkit
    European Journal of Clinical Investigation.2024;[Epub]     CrossRef
  • Adverse reactions to cosmetic implants after COVID‐19 vaccination: Correspondence
    Amnuay Kleebayoon, Viroj Wiwanitkit
    Journal of Cosmetic Dermatology.2024;[Epub]     CrossRef
  • Differences in lethality and diffusion of Covid-19 and different kinds of vaccines: Correspondence
    Hinpetch Daungsupawong, Viroj Wiwanitkit
    Journal of Public Health Research.2024;[Epub]     CrossRef
  • Immunogenicity of BNT162b2 vaccine after two and three doses: Correspondence
    H. Daungsupawong, V. Wiwanitkit
    Medicina de Familia. SEMERGEN.2024; 50(4): 102132.     CrossRef
  • Autoimmune Optic Neuropathy and COVID-19 Vaccine
    Amnuay Kleebayoon, Viroj Wiwanitkit
    Journal of Neuro-Ophthalmology.2024; 44(1): e206.     CrossRef
  • Comment on: Isolated Sixth Nerve Palsy and COVID-19
    Amnuay Kleebayoon, Viroj Wiwanitkit
    Journal of Neuro-Ophthalmology.2024;[Epub]     CrossRef
  • A trade-off between lives and the economy? Subsidizing dining out under the COVID-19 pandemic in Japan
    Yupeng Wang, Satoru Shimokawa
    Food Policy.2024; 124: 102625.     CrossRef
  • Cardiac inflammation associated with COVID-19 mRNA vaccination and previous myocarditis
    Rujittika MUNGMUNPUNTIPANTIP, Viroj WIWANITKIT
    Minerva Cardiology and Angiology.2024;[Epub]     CrossRef
  • COVID-19-induced acute kidney injury and chronic kidney disease: comment
    Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
    Brazilian Journal of Nephrology.2023; 45(2): 262.     CrossRef
  • Vaccination and SARS-CoV-2 seroprevalence in blood donors: Correspondence
    Pathum Sookaromdee, Viroj Wiwanitkit
    Transfusion Clinique et Biologique.2023; 30(1): 22.     CrossRef
  • Comments on “Serological response and safety of heterologous ChAdOx1-nCoV-19/mRNA-1273 prime-boost vaccination”
    Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
    Journal of the Formosan Medical Association.2023; 122(1): 82.     CrossRef
  • Comment on: “Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study”
    Pathum Sookaromdee, Viroj Wiwanitkit
    Digestive and Liver Disease.2023; 55(1): 11.     CrossRef
  • An autopsy case report of aortic dissection after mRNA COVID-19 vaccination: correspondence
    Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
    Legal Medicine.2023; 60: 102169.     CrossRef
  • Lesão renal aguda induzida por COVID-19 e doença renal crônica: comentário
    Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
    Brazilian Journal of Nephrology.2023; 45(2): 262.     CrossRef
  • Correspondence: Clinical Course of Adverse Effects after COVID-19 Vaccination
    Amnuay Kleebayoon, Viroj Wiwanitkit
    Korean Journal of Family Medicine.2023; 44(5): 299.     CrossRef
  • Long COVID-19 and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Correspondence
    Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
    Reumatología Clínica.2023; 19(2): 119.     CrossRef
  • COVID-19 Infection Risk, Elective Arthroplasty and Surgical Complications, and COVID-19 Vaccination: Correspondence
    Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
    Arthroplasty Today.2023; 19: 101064.     CrossRef
  • Response:
    Dongmei Li
    Allergy and Asthma Proceedings.2023; 44(1): e1a.     CrossRef
  • Long COVID-19 and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Correspondence
    Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
    Reumatología Clínica (English Edition).2023; 19(2): 119.     CrossRef
  • Salivary and serum IgA and IgG after COVID-19 and after immunization with COVID-19 vaccines
    Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
    Allergy and Asthma Proceedings.2023; 44(1): e1.     CrossRef
  • COVID-19 vaccines and increased blood pressure
    Amnuay Kleebayoon, Viroj Wiwanitkit
    European Journal of Internal Medicine.2023; 112: 121.     CrossRef
  • Cardiac magnetic resonance imaging findings in COVID-19 vaccine-related myocarditis
    Rujittika Mungmunpuntipantip, Wiwanitkit Viroj
    Infectious Diseases.2023; 55(4): 308.     CrossRef
  • Re: Ipsilateral Upper-Limb Lymphedema After COVID-19 Vaccine Booster
    Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
    Clinical Nuclear Medicine.2023; 48(9): 836.     CrossRef
  • Heterologous mRNA-based COVID-19 booster strategies: Comment
    Sora Yasri, Viroj Wiwanitkit
    Human Vaccines & Immunotherapeutics.2023;[Epub]     CrossRef
  • Comment on “COVID-19 vaccine efficacy”
    Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
    Journal of Investigative Medicine.2023; 71(3): 307.     CrossRef
  • Systemic lupus, immunosuppressives, COVID‐19 vaccination, and antibody response: comment on the article by Petri et al
    Amnuay Kleebayoon, Viroj Wiwanitkit
    Arthritis Care & Research.2023; 75(10): 2224.     CrossRef
  • Waning of humoral immunity and COVID-19 vaccine: comment
    Amnuay Kleebayoon, Viroj Wiwanitkit
    Infectious Diseases.2023; 55(4): 307.     CrossRef
  • Acute disseminated encephalomyelitis and COVID-19 vaccination: Comment
    Amnuay Kleebayoon, Viroj Wiwanitkit
    Journal of Clinical Neuroscience.2023; 115: 164.     CrossRef
  • Comment on COVID‐19 vaccination during pregnancy, COVID and maternal and neonatal outcomes
    Amnuay Kleebayoon, Viroj Wiwanitkit
    Reviews in Medical Virology.2023;[Epub]     CrossRef
  • Comments on: “Spectrum of Neurological Complications Following COVID-19 Vaccination in India”
    Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
    Journal of Clinical Neurology.2023; 19(3): 322.     CrossRef
  • SARS-CoV-2 vaccination in inflammatory bowel disease patients with different biological agents: correspondence
    Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
    Revista Española de Enfermedades Digestivas.2023;[Epub]     CrossRef
  • COVID-19 Vaccination in Patients Who Develop COVID-19 following Cancer Surgery: Correspondence
    Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
    Annals of Surgical Oncology.2023; 30(4): 2108.     CrossRef
  • COVID-19 Vaccine-Induced Immune Response in Oral Fluids and Serum: Correspondence
    Pathum Sookaromdee, Viroj Wiwanitkit
    International Dental Journal.2023; 73(2): 325.     CrossRef
  • Correspondence on “COVID-19 vaccination and pregnancy”
    Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
    Journal of Perinatal Medicine.2023; 51(7): 965.     CrossRef
  • COVID-19 vaccines and retinal microvasculature: Comment
    Amnuay Kleebayoon, Viroj Wiwanitkit
    Photodiagnosis and Photodynamic Therapy.2023; 42: 103306.     CrossRef
  • Correspondence: Neuropsychiatric post-acute sequelae of COVID-19
    Amnuay Kleebayoon, Viroj Wiwanitkit
    European Archives of Psychiatry and Clinical Neuroscience.2023;[Epub]     CrossRef
  • Antibody responses to second doses of COVID-19 vaccination in lung cancer patients: comment
    Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
    Respiratory Investigation.2023; 61(3): 332.     CrossRef
  • Audiological and vestibular symptoms following COVID-19 and COVID-19 vaccination in children: Correspondence
    Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
    American Journal of Otolaryngology.2023; 44(2): 103793.     CrossRef
  • Severe coronary artery spasm after administration of a 5-hydroxytryptamine type 1 receptor agonist and SARS-CoV2 vaccination: Comment
    Amnuay Kleebayoon, Viroj Wiwanitkit
    Acta Cardiologica.2023; 78(8): 974.     CrossRef
  • Correspondence on Body Weight, Anti-SARS-CoV-2 Antibody and mRNA Vaccination
    Pathum Sookaromdee, Viroj Wiwanitkit
    Infection & Chemotherapy.2023; 55(1): 109.     CrossRef
  • Multiple sclerosis patients’ response to COVID-19 pandemic and vaccination: correspondence
    Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
    The Egyptian Journal of Neurology, Psychiatry and Neurosurgery.2023;[Epub]     CrossRef
  • Severe treatment-refractory antibody positive autoimmune autonomic ganglionopathy and COVID19 vaccination: Correspondence
    Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
    Autoimmunity Reviews.2023; 22(2): 103233.     CrossRef
  • Letter regarding “COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis”
    Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
    Clinical and Molecular Hepatology.2023; 29(1): 168.     CrossRef
  • Anti-nucleocapsid level variation to assess SARS-CoV-2 seroprevalence: comment
    Amnuay Kleebayoon, Viroj Wiwanitkit
    Infectious Diseases.2023; 55(6): 446.     CrossRef
  • Letter to the Editor Regarding “The Effect of COVID-19 Vaccines on Stroke Outcomes: A Single-Center Study”
    Amnuay Kleebayoon, Viroj Wiwanitkit
    World Neurosurgery.2023; 171: 196.     CrossRef
  • COVID-19 vaccine type and Guillain-Barré syndrome: Comment
    Amnuay Kleebayoon, Viroj Wiwanitkit
    Human Vaccines & Immunotherapeutics.2023;[Epub]     CrossRef
  • Singing Voice Symptomatology and SARS-CoV-2 Infection: Correspondence
    Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
    Journal of Voice.2023; 37(4): 629.     CrossRef
  • Patients with type 2 diabetes mellitus and response to COVID-19 BNT162b2 mRNA vaccine: correspondence
    Pathum Sookaromdee, Viroj Wiwanitkit
    Hormones.2023; 22(1): 15.     CrossRef
  • Sputnik V vaccine-related complications and inflammatory biomarkers: Correspondence
    Pathum Sookaromdee, Viroj Wiwanitkit
    Indian Journal of Medical Microbiology.2023; 44: 100357.     CrossRef
  • Adverse effects and antibody responses following homologous and heterologous COVID19 prime-boost vaccinations
    Amnuay Kleebayoon, Viroj Wiwanitkit
    Journal of the Formosan Medical Association.2023; 122(5): 432.     CrossRef
  • Placental damage in pregnant women with SARS-CoV-2 infection: Comment
    Amnuay Kleebayoon, Viroj Wiwanitkit
    Placenta.2023; 136: 25.     CrossRef
  • Spike-specific humoral and cellular immune responses after COVID-19 mRNA vaccination in patients with cirrhosis
    Amnuay Keebayoon, Viroj Wiwanitkit
    Digestive and Liver Disease.2023; 55(3): 325.     CrossRef
  • Comment: Baricitinib Versus Tocilizumab for the Treatment of Moderate to Severe COVID-19
    Rujittika, PhD Mungmunpuntipantip, Viroj, MD Wiwanitkit
    Annals of Pharmacotherapy.2023; 57(9): 1117.     CrossRef
  • Safety and adverse events following COVID‐19 vaccination and epilepsy: Correspondence
    Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
    Epilepsia Open.2023; 8(1): 235.     CrossRef
  • Response to Hasdemir et al. (2023) COVID-19 vaccinations on menstrual cycle and serum anti-Mullerian hormone levels
    Amnuay Kleebayoon, Viroj Wiwanitkit
    Human Fertility.2023; 26(1): 186.     CrossRef
  • CoronaVac, BNT162b2 and heterologous COVID-19 vaccine and ventricular assist device: Correspondence
    Amnuay Kleebayoon, Viroj Wiwanitkit
    The International Journal of Artificial Organs.2023; 46(5): 255.     CrossRef
  • COVID‐19 infection and vaccination in pancreatobiliary IgG4‐related disease patients: Correspondence
    P Sookaromdee, V Wiwanitkit
    Journal of Gastroenterology and Hepatology.2023; 38(3): 476.     CrossRef
  • Letter to the editor: COVID‐19 vaccinations in pregnancy
    Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
    International Journal of Gynecology & Obstetrics.2023; 160(2): 719.     CrossRef
  • COVID-19 vaccination and idiopathic sudden sensorineural hearing loss: comment
    Amnuay Kleebayoon, Viroj Wiwanitkit
    European Archives of Oto-Rhino-Laryngology.2023; 280(9): 4303.     CrossRef
  • Cytokine levels in maternal and infant blood after COVID-19 vaccination during pregnancy: Correspondence
    Amnuay Kleebayoon, Viroj Wiwanitkit
    Journal of Reproductive Immunology.2023; 157: 103947.     CrossRef
  • Bilateral retinal vein occlusion after COVID-19 vaccination: Correspondence
    R.M. Unpuntipantip, V. Wiwanitkit
    Journal Français d'Ophtalmologie.2023; 46(2): e53.     CrossRef
  • SARS-CoV-2 infection, vaccination and acquired hemophilia: Correspondence
    Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
    Thrombosis Research.2023; 230: 153.     CrossRef
  • COVID‐19 vaccination and rheumatoid arthritis in older patients: Correspondence
    Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
    Geriatrics & Gerontology International.2023; 23(1): 66.     CrossRef
  • Development of myocarditis and pericarditis after COVID‐19 vaccination: Comment
    Amnuay Kleebayoon, Viroj Wiwanitkit
    Clinical Cardiology.2023; 46(4): 459.     CrossRef
  • Correspondence on functional neurological disorders after COVID-19 and SARS-CoV-2 vaccines
    Amnuay Kleebayoon, Viroj Wiwanitkit
    Journal of Neurology, Neurosurgery & Psychiatry.2023; 94(9): 780.     CrossRef
  • Central diabetes insipidus, hypophysitis and SARS-CoV-2 vaccine: Correspondence
    Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
    Therapies.2023; 78(4): 456.     CrossRef
  • Coronavirus disease 2019 vaccine effectiveness among a population-based cohort of people with HIV
    Pathum Sookaromdee, Viroj Wiwanitkit
    AIDS.2023; 37(2): 365.     CrossRef
  • Miocarditis por lupus eritematoso sistémico y vacunación contra la COVID-19: comentario
    Amnuay Kleebayoon, Viroj Wiwanitkit
    Reumatología Clínica.2023; 19(6): 349.     CrossRef
  • Response to Hasdemir et al. (2023) COVID-19 vaccinations on menstrual cycle and serum anti-Mullerian hormone levels
    Amnuay Kleebayoon, Viroj Wiwanitkit
    Human Fertility.2023; 26(6): 1636.     CrossRef
  • RE: “RISK AND BENEFIT OF mRNA COVID-19 VACCINES FOR THE OMICRON VARIANT BY AGE, SEX, AND PRESENCE OF COMORBIDITY: A QUALITY-ADJUSTED LIFE YEARS ANALYSIS”
    Amnuay Kleebayoon, Viroj Wiwanitkit
    American Journal of Epidemiology.2023; 192(6): 1031.     CrossRef
  • COVID-19 Vaccination Safety Profiles in Patients with Solid Tumour Cancers: Comment
    A. Kleebayoon, V. Wiwanitkit
    Clinical Oncology.2023; 35(7): 483.     CrossRef
  • Competition between variants and SARS-Co-V2 epidemic, from Wuhan to XBB.1.16.: Natural selection?
    Amnuay Kleebayoon, Viroj Wiwanitkit
    European Journal of Internal Medicine.2023; 113: 110.     CrossRef
  • Comment on: Kikuchi–Fujimoto disease following SARS‐CoV‐2 vaccination in a patient with previous history of rhabdomyosarcoma
    Amnuay Kleebayoon, Viroj Wiwanitkit
    Pediatric Blood & Cancer.2023;[Epub]     CrossRef
  • Side effects of COVID-19 vaccination and breast cancer
    Amnuay Kleebayoon, Viroj Wiwanitkit
    Clinical and Experimental Medicine.2023; 23(7): 4035.     CrossRef
  • Immunogenicity, effectiveness and safety of COVID-19 vaccine in older adults living in nursing homes: Comment
    Amnuay Kleebayoon, Viroj Wiwanitkit
    Revista Española de Geriatría y Gerontología.2023; 58(3): 174.     CrossRef
  • Systemic lupus erythematosus myocarditis and COVID-19 vaccination: Comment
    Amnuay Kleebayoon, Viroj Wiwanitkit
    Reumatología Clínica (English Edition).2023; 19(6): 349.     CrossRef
  • Correspondence on the evaluation of patients with COVID-19 vaccine side effects
    Amnuay Kleebayoon, Viroj Wiwanitkit
    Revista da Associação Médica Brasileira.2023;[Epub]     CrossRef
  • Comment on the effectiveness of four SARS-COV-2 vaccines
    Amnuay Kleebayoon, Viroj Wiwanitkit
    Atención Primaria.2023; 55(7): 102655.     CrossRef
  • Postvaccination Immunogenicity of COVID-19 Vaccine in Pediatric Inflammatory Bowel Disease: Comment
    Amnuay Kleebayoon, Viroj Wiwanitkit
    Journal of Pediatric Gastroenterology & Nutrition.2023; 76(6): e89.     CrossRef
  • Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines Against COVID-19 Hospitalizations: Comment
    Amnuay Kleebayoon, Viroj Wiwanitkit
    Open Forum Infectious Diseases.2023;[Epub]     CrossRef
  • Humoral response to COVID-19 vaccination and maintenance hemodialysis: Correspondence
    Rujititka Mungmunpuntipantip, Viroj Wiwanitkit, Amnuay Kleebayoon
    Medicina Clínica.2023; 161(7): 315.     CrossRef
  • Inactivated (SARS-CoV-2) Vaccine, Retrobulbar Vascular Blood Flow and Retinal Vascular Density
    Amnuay Kleebayoon, Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
    Photodiagnosis and Photodynamic Therapy.2023; 43: 103652.     CrossRef
  • Fulminant myocarditis following SARS-CoV-2 mRNA vaccination
    Amnuay Kleebayoon, Viroj Wiwanitkit
    Perfusion.2023; : 026765912311818.     CrossRef
  • Parsonage–Turner Syndrome and COVID-19 Vaccine: Correspondence
    Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
    Annals of Indian Academy of Neurology.2023; 26(3): 300.     CrossRef
  • Left Ventricular Function in Patients with Myopericarditis After mRNA COVID-19 Vaccination: Comment
    Amnuay Kleebayoon, Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
    Pediatric Cardiology.2023; 44(7): 1632.     CrossRef
  • SARS-CoV-2 vaccination for unexpected death from atrial myocarditis: Comment
    Amnuay Kleebayoon, Viroj Wiwanitkit
    Legal Medicine.2023; 64: 102283.     CrossRef
  • Comment on immunity to COVID-19 vaccination in patients with liver disease and transplant recipients
    Amnuay Kleebayoon, Viroj Wiwanitkit
    Hepatology Communications.2023;[Epub]     CrossRef
  • Side Effects Comparison of Coronavirus Vaccines Among Healthcare Workers: Comment
    Amnuay Kleebayoon, Viroj Wiwanitkit
    Clinical Pathology.2023;[Epub]     CrossRef
  • Comment on: Humoral profiling of pediatric patients with cancer reveals robust immunity following anti‐SARS‐CoV‐2 vaccination superior to natural infection
    Amnuay Kleebayoon, Viroj Wiwanitkit
    Pediatric Blood & Cancer.2023;[Epub]     CrossRef
  • Major cardiovascular events after COVID-19, event rates post-vaccination, antiviral or anti-inflammatory therapy, and temporal trends: Correspondence
    Amnuay Kleebayoon, Viroj Wiwanitkit
    Thrombosis Research.2023; 229: 40.     CrossRef
  • Immunogenicity, safety and efficacy of COVID-19 vaccine: Correspondence
    Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
    Indian Journal of Medical Microbiology.2023; 45: 100387.     CrossRef
  • Generalized Eosinophilia Following Moderna COVID-19 Vaccine Administration: Comment
    Amnuay Kleebayoon, Viroj Wiwanitkit
    Academic Forensic Pathology.2023; 13(2): 86.     CrossRef
  • Prior SARS-COV-2 infection, vaccination, COVID-19 hospital admission and mortality amongst nursing home residents: comment
    Amnuay Kleebayoon, Viroj Wiwanitkit
    Aging Clinical and Experimental Research.2023; 35(9): 1977.     CrossRef
  • Stroke after SARS-CoV-2 vaccination: Comment
    Amnuay Kleebayoon, Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
    Clinics.2023; 78: 100246.     CrossRef
  • COVID-19 and IgA Vasculitis
    Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
    The Journal of Rheumatology.2023; 50(7): 969.     CrossRef
  • Homologous or heterologous immunization regimens against SARS-CoV-2 after two doses of inactivated COVID-19 vaccine: Comment
    Rujitika Mungmunpuntipantip, Viroj Wiwanitkit
    Human Vaccines & Immunotherapeutics.2023;[Epub]     CrossRef
  • Efficacy of COVID‐19 vaccination in adult patients with sickle cell disease: Comment
    Amnuay Kleebayoon, Viroj Wiwanitkit
    European Journal of Haematology.2023; 111(4): 666.     CrossRef
  • COVID-19 Vaccine Associated with Cutaneous Involvement: Correspondence
    Viroj Wiwanitkit, Rujittika Mungmunpuntipantip
    Indian Journal of Critical Care Medicine.2023; 27(8): 599.     CrossRef
  • Letter to the Editor From Kleebayoon and Wiuwanikit: “Subacute THYROiditis Related to SARS-CoV-2 VAccine and Covid-19 (THYROVAC Study): A Multicenter Nationwide Study”
    Amnuay Kleebayoon, Viroj Wiwanitkit
    The Journal of Clinical Endocrinology & Metabolism.2023; 109(1): e432.     CrossRef
  • Self-reported side effects following COVID-19 vaccination in athletes: Correspondence
    Pathum Sookaromdee, Viroj Wiwanitkit
    Human Vaccines & Immunotherapeutics.2023;[Epub]     CrossRef
  • SARS-CoV-2 Serological Response in Patients With Inflammatory Bowel Disease
    Amnuay Kleebayoon, Viroj Wiwanitkit
    Inflammatory Bowel Diseases.2023; 29(11): e44.     CrossRef
  • COVID‐19 vaccination and myasthenia gravis
    Amnuay Kleebayoon, Viroj Wiwanitkit
    European Journal of Neurology.2023; 30(12): 3988.     CrossRef
  • Humoral response to COVID-19 vaccination and maintenance hemodialysis: Correspondence
    Rujititka Mungmunpuntipantip, Viroj Wiwanitkit, Amnuay Kleebayoon
    Medicina Clínica (English Edition).2023; 161(7): 315.     CrossRef
  • Axillary lymph nodes enlargement after Sars-CoV-2 vaccine in patients undergoing breast examination: comment
    Amnuay Kleebayoon, Viroj Wiwanitkit
    La radiologia medica.2023; 128(12): 1593.     CrossRef
  • Livedoid skin reaction and mRNA Covid-19 vaccine: correspondence
    Rujittika Mungunpuntipantip, Viroj Wiwanitkit
    Pathologica.2023; 115(4): 246.     CrossRef
  • Post-Vaccine SARS-CoV-2 Reinfection and Associated Factors Among Health Care Providers: Comment
    Amnuay Kleebayoon, Viroj Wiwanitkit
    Health Services Research and Managerial Epidemiology.2023;[Epub]     CrossRef
  • Comment on “Effect of COVID vaccination on monthly migraine days”
    Hinpetch Daungsupawong, Viroj Wiwanitkit
    Cephalalgia.2023;[Epub]     CrossRef
  • Humoral Response After 5 Successive Doses of COVID-19 Vaccine in Kidney Transplant Patients: Comment
    Amnuay Kleebayoon, Viroj Wiwanitkit
    Transplantation.2023; 107(11): e318.     CrossRef
  • Intraneural ganglion cyst of the peroneal nerve and coronavirus disease-19 vaccination: Relationship and possible mechanism
    Somsri Wiwanitkit, Viroj Wiwanitkit
    Human Vaccines & Immunotherapeutics.2023;[Epub]     CrossRef
  • Hemophagocytic lymphohistiocytosis (HLH) after COVID-19 vaccination
    Somsri Wiwanitkit, Viroj Wiwanitkit
    Human Vaccines & Immunotherapeutics.2023;[Epub]     CrossRef
  • COVID-19 infection and vaccination among children
    Amnuay Kleebayoon, Viroj Wiwanitkit
    Clinical and Experimental Pediatrics.2023; 66(12): 531.     CrossRef
  • Humoral response against spike protein and fifth and sixth COVID-19 mRNA vaccine in the uninfected and infected subjects: What should be for the seventh dose?
    Somsri Wiwanitkit, Viroj Wiwanitkit
    Human Vaccines & Immunotherapeutics.2023;[Epub]     CrossRef
  • Comment on “Re‐infection with SARS‐CoV‐2 in solid‐organ transplant recipients”
    Pathum Sookaromdee, Viroj Wiwanitkit
    Transplant Infectious Disease.2022;[Epub]     CrossRef
  • Antibody response to the messenger RNA corona virus disease 2019 vaccine in liver transplant recipients
    Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
    Hepatology Communications.2022; 6(7): 1840.     CrossRef
  • Re: Post-COVID-19 syndrome and humoral response association after one year in vaccinated and unvaccinated patients by Peghin et al.
    Pathum Sookaromdee, Viroj Wiwanitkit
    Clinical Microbiology and Infection.2022; 28(10): 1396.     CrossRef
  • COVID-19 Vaccination and Anti-CD19 CAR T Cell-Induced B Cell Aplasia
    Pathum Sookaromdee, Viroj Wiwanitkit
    Transplantation and Cellular Therapy.2022; 28(8): 515.     CrossRef
  • Correspondence on “Immunogenicity of COVID-19 Vaccine Doses in Patients With Inflammatory Bowel Disease”
    Pathum Sookaromdee, Viroj Wiwanitkit
    Inflammatory Bowel Diseases.2022; 28(10): e142.     CrossRef
  • Correspondence on artificial intelligence algorithm for COVID-19 pneumonia
    Pathum Sookaromdee, Viroj Wiwanitkit
    Japanese Journal of Radiology.2022; 40(8): 859.     CrossRef
  • Acute kidney injury after COVID-19 vaccines: correspondence
    Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
    Renal Failure.2022; 44(1): 1070.     CrossRef
  • Re: Heterologous Gam-COVID-Vac (Sputnik V)/mRNA-1273 (Moderna) vaccination
    Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
    Clinical Microbiology and Infection.2022; 28(11): 1513.     CrossRef
  • COVID-19 vaccination and lung transplant recipients
    Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
    Indian Journal of Thoracic and Cardiovascular Surgery.2022; 38(S2): 354.     CrossRef
  • Kidney Transplant Recipients With COVID-19 and Monoclonal Antibody Therapy: Additional Considerations
    Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
    Kidney Medicine.2022; 4(8): 100502.     CrossRef
  • Comment on D’Addio et al. Immunogenicity and Safety of SARS-CoV-2 mRNA Vaccines in a Cohort of Patients With Type 1 Diabetes. Diabetes 2022;71:1800–1806
    Pathum Sookaromdee, Viroj Wiwanitkit
    Diabetes.2022; 71(9): e13.     CrossRef
  • COVID-19, vaccination and neuropsychiatric sequelae: Correspondence
    Sora Yasri, Viroj Wiwanitkit
    Brain, Behavior, and Immunity.2022; 106: 112.     CrossRef
  • Comment on ”Humoral and cellular response to a third booster dose SARS-CoV- 2 vaccination in patients with autoimmune disease: a case series“
    P Sookaromdee, V Wiwanitkit
    Scandinavian Journal of Rheumatology.2022; 51(6): 527.     CrossRef
  • Third dose of mRNA COVID‐19 vaccine and response: Correspondence
    Pathum Sookaromdee, Viroj Wiwanitkit
    Liver International.2022; 42(10): 2342.     CrossRef
  • Kinetics of cellular and humoral responses to third COVID-19 vaccine in heart transplant recipients: Correspondence
    Pathum Sokaromdee, Viroj Wiwanitkit
    The Journal of Heart and Lung Transplantation.2022; 41(11): 1649.     CrossRef
  • Antibody response to coronavirus disease 2019 vaccines after allergic reaction to first dose
    Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
    Annals of Allergy, Asthma & Immunology.2022; 129(3): 388.     CrossRef
  • Correspondence on Outcomes of COVID-19 in Unvaccinated Compared With Vaccinated Solid Organ Transplant Recipients
    Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
    Transplantation.2022; 106(10): e461.     CrossRef
  • Kinetics of cellular and humoral responses to third BNT162B2 COVID-19 vaccine over six months in heart transplant recipients - Implications for the omicron variant: Correspondence
    Yael Peled, Jignseh K. Patel, Arnon Afek, Michal Mandelboim
    The Journal of Heart and Lung Transplantation.2022; 41(11): 1649.     CrossRef
  • Correspondence on ‘COVID-19 vaccine efficacy in a rapidly changing landscape’
    Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
    Journal of Investigative Medicine.2022; 70(6): 1442.     CrossRef
  • Comment on “Heterologous adenovirus‐vector/messenger RNA regimen, humoral response and liver transplant recipients”
    Pathum Sookaromdee, Viroj Wiwanitkit
    Hepatology Communications.2022; 6(12): 3598.     CrossRef
  • Comment on “immune response to SARS-CoV-2 mRNA vaccines in patients treated with either Ibrutinib or Rituximab”
    Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
    Clinical and Experimental Medicine.2022; 23(3): 955.     CrossRef
  • Giant cell vasculitis post-COVID-19 mRNA vaccine and COVID-19 asymptomatic infection: Correspondence
    Pathum Sookaromdee, Viroj Wiwanitkit
    Vascular.2022; : 170853812211373.     CrossRef
  • Drug induced hepatitis and SARS-CoV-2 vaccination: Correspondence
    Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
    Clinics and Research in Hepatology and Gastroenterology.2022; 46(10): 102034.     CrossRef
  • Efficacy and impact of SARS-CoV-2 vaccination on cancer treatment for breast cancer patients: correspondence
    Rujittika Mungmunpuntipanjtip, Won Sriwijitalai, Viroj Wiwanitkit
    Breast Cancer Research and Treatment.2022; 196(1): 239.     CrossRef
  • Seroconversion after COVID‐19 vaccination and heart transplant recipients: Correspondence
    Won Sriwijitalai, Viroj Wiwanitkit
    Transplant Infectious Disease.2022;[Epub]     CrossRef
  • Therapy in Patients with Hematologic Malignancies, Seroconversion Rates, and SARS-CoV-2 Vaccination
    Won Sriwijitalai, Viroj Wiwanitkit
    The Oncologist.2022; 27(11): e916.     CrossRef
  • Correspondence on “Anti-SARS-Co-2 Monoclonal Antibodies and Severe Covid-19 in Kidney Transplant Patients”
    Pathum Sookaromdee, Viroj Wiwanitkit
    Kidney International Reports.2022; 7(10): 2319.     CrossRef
  • Sotrovimab administration in vaccinated and unvaccinated kidney transplant recipients with SARS‐CoV‐2 infection: Correspondence
    Pathum Sookaromdee, Viroj Wiwanitkit
    Transplant Infectious Disease.2022;[Epub]     CrossRef
  • Disease profile and patient outcomes in vaccinated COVID-19 patients
    Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
    Medical Journal Armed Forces India.2022; 78(4): 497.     CrossRef
  • Impact of COVID-19 pandemic in terms of incidence and lethality in nursing homes
    Pathum Sookaromdee, Viroj Wiwanitkit
    Revista Española de Geriatría y Gerontología.2022; 57(6): 337.     CrossRef
  • SARS-CoV-2 mRNA vaccination, prostate cancer and steroids: Correspondence
    Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
    Urologic Oncology: Seminars and Original Investigations.2022; 40(12): 541.     CrossRef
  • Surrogate neutralization responses following SARS-CoV-2 vaccination in people with HIV
    Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
    AIDS.2022; 36(12): 1746.     CrossRef
  • Factors Associated With COVID-19 Breakthrough Infections: Correspondence
    Rujitika Mungmunpuntipantip, Viroj Wiwanitkit
    Journal of Occupational & Environmental Medicine.2022; 64(11): e793.     CrossRef
  • Safety of mRNA BNT162b2 COVID-19 (Pfizer-BioNtech) vaccine in children aged 5-11 years: Correspondence
    Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
    Human Vaccines & Immunotherapeutics.2022;[Epub]     CrossRef
  • Immunity after mRNA COVID-19 vaccine and immunosuppressive therapy: correspondence
    Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
    Acta Dermatovenerologica Alpina Pannonica et Adriatica.2022;[Epub]     CrossRef
  • Split-dosing of coronavirus disease 2019 vaccines
    Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
    Annals of Allergy, Asthma & Immunology.2022; 129(6): 799.     CrossRef
  • Multiple sites of thrombosis without thrombocytopenia and COVID-19 vaccine: Correspondence
    Rujittika Mungunpuntipantip, Viroj Wiwanitkit
    International Journal of Immunopathology and Pharmacology.2022; 36: 039463202211489.     CrossRef
  • COVID-19 Vaccination in Cancer Patients: Correspondence
    Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
    Cancer Control.2022; 29: 107327482211427.     CrossRef
  • Antibody Response to SARS-CoV-2 mRNA Vaccine Among Kidney Transplant Recipients
    Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
    Experimental and Clinical Transplantation.2022; 20(11): 1048.     CrossRef
  • Work within the COVID-19 pandemic — the experience of the biobank of the National Medical Research Center of Oncology
    I. V. Samokhina, A. B. Sagakyants
    Cardiovascular Therapy and Prevention.2020; 19(6): 2741.     CrossRef

JPMPH : Journal of Preventive Medicine and Public Health